These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


192 related items for PubMed ID: 2570456

  • 1. Drug interactions with quinolones.
    Davies BI, Maesen FP.
    Rev Infect Dis; 1989; 11 Suppl 5():S1083-90. PubMed ID: 2570456
    [Abstract] [Full Text] [Related]

  • 2. Drug interactions with quinolone antibacterials.
    Brouwers JR.
    Drug Saf; 1992; 7(4):268-81. PubMed ID: 1524699
    [Abstract] [Full Text] [Related]

  • 3. Overview of drug interactions with the quinolones.
    Davey PG.
    J Antimicrob Chemother; 1988 Sep; 22 Suppl C():97-107. PubMed ID: 3053579
    [Abstract] [Full Text] [Related]

  • 4. Drug interactions with quinolones.
    Janknegt R.
    J Antimicrob Chemother; 1990 Nov; 26 Suppl D():7-29. PubMed ID: 2286594
    [Abstract] [Full Text] [Related]

  • 5. The effects of quinolones on xanthine pharmacokinetics.
    Robson RA.
    Am J Med; 1992 Apr 06; 92(4A):22S-25S. PubMed ID: 1580270
    [Abstract] [Full Text] [Related]

  • 6. Drug interactions with quinolones.
    Lode H.
    Rev Infect Dis; 1988 Apr 06; 10 Suppl 1():S132-6. PubMed ID: 3279488
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics of gyrase inhibitors, Part 2: Renal and hepatic elimination pathways and drug interactions.
    Sörgel F, Kinzig M.
    Am J Med; 1993 Mar 22; 94(3A):56S-69S. PubMed ID: 8383921
    [Abstract] [Full Text] [Related]

  • 9. Indomethacin/ibuprofen-like anti-inflammatory agents selectively potentiate the gamma-aminobutyric acid-antagonistic effects of several norfloxacin-like quinolone antibacterial agents on [35S]t-butylbicyclophosphorothionate binding.
    Squires RF, Saederup E.
    Mol Pharmacol; 1993 May 22; 43(5):795-800. PubMed ID: 8388990
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Pharmacokinetics of the newer fluoroquinolones.
    Brouwers JR.
    Pharm Weekbl Sci; 1987 Dec 11; 9 Suppl():S16-22. PubMed ID: 3325926
    [Abstract] [Full Text] [Related]

  • 14. Structure-epileptogenicity relationship of quinolones with special reference to their interaction with gamma-aminobutyric acid receptor sites.
    Akahane K, Sekiguchi M, Une T, Osada Y.
    Antimicrob Agents Chemother; 1989 Oct 11; 33(10):1704-8. PubMed ID: 2556076
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacokinetic interactions between theophylline and other medication (Part I).
    Upton RA.
    Clin Pharmacokinet; 1991 Jan 11; 20(1):66-80. PubMed ID: 1674242
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Update on quinolone drug interactions.
    Hulisz D, Miller K.
    Am Pharm; 1990 Sep 11; NS30(9):34-6. PubMed ID: 2220561
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.